Skip to main content
Equibles
TWST logo

TWST · Twist Bioscience Corp · Analyst Estimates

Track TWST — free

Use TWST with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TWST.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$161.00 +1.15 (+0.72%) Q3 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$9.84B
Shares
62.71M
Volume · Oct 27 1.76M Avg daily vol (3M) 2.25M

Analyst Estimates

Compare analyst forecasts for Twist Bioscience Corp across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-24 04:32 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-09-30

Analyst estimates for FY ending 2026-09-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-2.14
-1.20
-0.57
5
-0.96
-0.96
-1.08
-1.19
0
0
2
2
Revenue
USD
Publication date not stated
455.90M
456.30M
457.09M
12
 — — — — — — — —

FY ending 2027-09-30

Analyst estimates for FY ending 2027-09-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-1.12
-0.40
0.10
4
-0.75
-0.75
-0.78
-1.00
0
0
1
1
Revenue
USD
Publication date not stated
532.40M
548.64M
559.88M
11
 — — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.38
-0.20
-0.02
4
-0.15
-0.15
-0.15
-0.19
1
1
0
0
Revenue
USD
Publication date not stated
123.08M
123.58M
124.30M
11
 — — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.31
-0.14
-0.04
3
-0.16
-0.16
-0.16
-0.095
0
0
1
1
Revenue
USD
Publication date not stated
124.00M
126.42M
128.13M
8
 — — — — — — — —
Key facts CIK 1581280 CUSIP 90184D100 13F (30d) 73 filings 68 filers Visit website Investor relations